Correction: Panjideh et al. Improved Therapy of B-Cell Non-Hodgkin Lymphoma by Obinutuzumab-Dianthin Conjugates in Combination with the Endosomal Escape Enhancer SO1861. <i>Toxins</i> 2022, <i>14</i>, 478
The authors wish to make corrections to their paper [...]
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2022-10-01
|
| Series: | Toxins |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2072-6651/14/10/703 |
| _version_ | 1827647868298592256 |
|---|---|
| author | Hossein Panjideh Nicole Niesler Alexander Weng Hendrik Fuchs |
| author_facet | Hossein Panjideh Nicole Niesler Alexander Weng Hendrik Fuchs |
| author_sort | Hossein Panjideh |
| collection | DOAJ |
| description | The authors wish to make corrections to their paper [...] |
| first_indexed | 2024-03-09T19:24:36Z |
| format | Article |
| id | doaj.art-1c95e24a8a6f433e9e4e31f883eda528 |
| institution | Directory Open Access Journal |
| issn | 2072-6651 |
| language | English |
| last_indexed | 2024-03-09T19:24:36Z |
| publishDate | 2022-10-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Toxins |
| spelling | doaj.art-1c95e24a8a6f433e9e4e31f883eda5282023-11-24T02:59:24ZengMDPI AGToxins2072-66512022-10-01141070310.3390/toxins14100703Correction: Panjideh et al. Improved Therapy of B-Cell Non-Hodgkin Lymphoma by Obinutuzumab-Dianthin Conjugates in Combination with the Endosomal Escape Enhancer SO1861. <i>Toxins</i> 2022, <i>14</i>, 478Hossein Panjideh0Nicole Niesler1Alexander Weng2Hendrik Fuchs3Charité—Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Institute of Diagnostic Laboratory Medicine, Clinical Chemistry and Pathobiochemistry, Augustenburger Platz 1, D-13353 Berlin, GermanyCharité—Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Institute of Diagnostic Laboratory Medicine, Clinical Chemistry and Pathobiochemistry, Augustenburger Platz 1, D-13353 Berlin, GermanyInstitut für Pharmazie, Freie Universität Berlin, Königin-Luise-Straße 2+4, D-14195 Berlin, GermanyCharité—Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Institute of Diagnostic Laboratory Medicine, Clinical Chemistry and Pathobiochemistry, Augustenburger Platz 1, D-13353 Berlin, GermanyThe authors wish to make corrections to their paper [...]https://www.mdpi.com/2072-6651/14/10/703n/a |
| spellingShingle | Hossein Panjideh Nicole Niesler Alexander Weng Hendrik Fuchs Correction: Panjideh et al. Improved Therapy of B-Cell Non-Hodgkin Lymphoma by Obinutuzumab-Dianthin Conjugates in Combination with the Endosomal Escape Enhancer SO1861. <i>Toxins</i> 2022, <i>14</i>, 478 Toxins n/a |
| title | Correction: Panjideh et al. Improved Therapy of B-Cell Non-Hodgkin Lymphoma by Obinutuzumab-Dianthin Conjugates in Combination with the Endosomal Escape Enhancer SO1861. <i>Toxins</i> 2022, <i>14</i>, 478 |
| title_full | Correction: Panjideh et al. Improved Therapy of B-Cell Non-Hodgkin Lymphoma by Obinutuzumab-Dianthin Conjugates in Combination with the Endosomal Escape Enhancer SO1861. <i>Toxins</i> 2022, <i>14</i>, 478 |
| title_fullStr | Correction: Panjideh et al. Improved Therapy of B-Cell Non-Hodgkin Lymphoma by Obinutuzumab-Dianthin Conjugates in Combination with the Endosomal Escape Enhancer SO1861. <i>Toxins</i> 2022, <i>14</i>, 478 |
| title_full_unstemmed | Correction: Panjideh et al. Improved Therapy of B-Cell Non-Hodgkin Lymphoma by Obinutuzumab-Dianthin Conjugates in Combination with the Endosomal Escape Enhancer SO1861. <i>Toxins</i> 2022, <i>14</i>, 478 |
| title_short | Correction: Panjideh et al. Improved Therapy of B-Cell Non-Hodgkin Lymphoma by Obinutuzumab-Dianthin Conjugates in Combination with the Endosomal Escape Enhancer SO1861. <i>Toxins</i> 2022, <i>14</i>, 478 |
| title_sort | correction panjideh et al improved therapy of b cell non hodgkin lymphoma by obinutuzumab dianthin conjugates in combination with the endosomal escape enhancer so1861 i toxins i 2022 i 14 i 478 |
| topic | n/a |
| url | https://www.mdpi.com/2072-6651/14/10/703 |
| work_keys_str_mv | AT hosseinpanjideh correctionpanjidehetalimprovedtherapyofbcellnonhodgkinlymphomabyobinutuzumabdianthinconjugatesincombinationwiththeendosomalescapeenhancerso1861itoxinsi2022i14i478 AT nicoleniesler correctionpanjidehetalimprovedtherapyofbcellnonhodgkinlymphomabyobinutuzumabdianthinconjugatesincombinationwiththeendosomalescapeenhancerso1861itoxinsi2022i14i478 AT alexanderweng correctionpanjidehetalimprovedtherapyofbcellnonhodgkinlymphomabyobinutuzumabdianthinconjugatesincombinationwiththeendosomalescapeenhancerso1861itoxinsi2022i14i478 AT hendrikfuchs correctionpanjidehetalimprovedtherapyofbcellnonhodgkinlymphomabyobinutuzumabdianthinconjugatesincombinationwiththeendosomalescapeenhancerso1861itoxinsi2022i14i478 |